Home Dermatology PDF: Risankizumab in Adults with Psoriatic Arthritis
PDF: Risankizumab in Adults with Psoriatic Arthritis
$1.99
PDF Download: Explore risankizumab for Psoriatic arthritis: Beyond ACR, it significantly improves enthesitis, dactylitis, and QoL scores like HAQ-DI. Promising in efficacy and safety, with full 208-week study results anticipated for a complete understanding.
Read online:
Risankizumab in Adults with Psoriatic Arthritis